News Detail

LifeWatch AG: Cancellation of all remaining publicly held registered shares of LifeWatch AG and delisting from the SIX Swiss Exchange, effective December 29, 2017

LifeWatch AG / Key word(s): Delisting/Delisting

18-Dec-2017 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.


LifeWatch AG: Cancellation of all remaining publicly held registered shares of LifeWatch AG and delisting from the SIX Swiss Exchange, effective December 29, 2017


Zug/Switzerland, December 18, 2017 - By decision dated December 6, 2017, the Supreme Court of the Canton of Zug declared all publicly held registered shares of LifeWatch AG with a nominal value of CHF 1.30 each (LifeWatch Shares) as cancelled in accordance with art. 137 of the Federal Act on Financial Market Infrastructures and Market Conduct in Securities and Derivatives Trading (FMIA).

The former holders of the cancelled LifeWatch Shares will be paid a cash and stock compensation in the amount of 0.1617 BioTelemetry Common Stock along with CHF 10.00 in cash (Main Compensation), or at the choice of each former holder of LifeWatch Shares, 0.2350 BioTelemetry Common Stock along with CHF 8.00 in cash (Alternative Compensation) for each cancelled LifeWatch Share, corresponding to the offer consideration paid by Cardiac Monitoring Holding Company, LLC in its tender offer for all publicly held LifeWatch Shares. The settlement of the cash and stock compensation will take place beginning of 2018.

In a decision dated October 25, 2017, SIX Exchange Regulation approved the delisting of the LifeWatch Shares from SIX Swiss Exchange. The delisting will take place on December 29, 2017, and the last day of trading of the LifeWatch Shares will be December 28, 2017.


For further questions:
LifeWatch AG
Andrew Moore, CFO
Mobile +41 79 216 29 46
office@gobio.com

About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland, Israel and Turkey, and is the parent company of LifeWatch Services Inc., LifeWatch Technologies, Ltd. and LifeWatch Turkey Holding AG (joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading manufacturer of digital health products. LifeWatch Sağlık Hizmetlerine A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and provider of mobile cardiac telemetry services in Turkey. For additional information, please visit www.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
https://www.lifewatch.com/Investor-Relations/Alert-Service.html

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, the business strategy, and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.


Additional features:


Document: http://n.eqs.com/c/fncls.ssp?u=OCBSVNHWFJ
Document title: LifeWatch AG: Cancellation of all remaining publicly held registered shares of LifeWatch AG and delisting from the SIX Swiss Exchange, effective December 29, 2017

End of ad hoc announcement

show this
[back]